Verana is a portfolio company of our VC firm, MedTech Venture Partners.

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

Startup Verana Health has inked a deal with a third medical association to analyze the medical records of millions of patients and help doctors take a data-driven approach to treating disease.

In a collaboration with the American Urological Association (AUA), Verana Health will be able to mine de-identified data from the organization’s clinical data registry. The registry features clinical data from more than 6.3 million unique patients and 37.8 million visits, including 10% of the nation’s prostate cancer patients.

The San Francisco-based startup—which is backed by GV, formerly known as Google Ventures—partners with medical associations to analyze large data sets of de-identified patient data in eye diseases, neurology and now urology. This information can accelerate the development of drugs, medical devices and new treatments, the company said.

The company’s platform started with eye care, incorporating electronic health record (EHR) data from the American Academy of Ophthalmology’s IRIS patient registry—which features more than 72 million unique patients in its database, 343 million visits and billions of data points—to improve ophthalmic patient care.

Read the full story at Fierce Healthcare